Skip to main content

Table 1 Characteristics of patients with end-stage renal disease and population control at study entry

From: Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study

Variable

ESRD individuals (N = 10,908)

Population controls (N = 189,850)

Median years of follow-up, (interquartile range)

2.3 (0.8–5.1)

6.4 (2.9–10.5)

Age at entry (N = 200,758)

16-49

2,481 (22.7%)

39,901 (21.0%)

50-64

3,314 (30.4%)

57,471 (30.3%)

65+

5,113 (46.9%)

92,478 (48.7%)

Sex (N = 200,758)

Female

4,059 (37.2%)

71,664 (37,7%)

Male

6,849 (62.8%)

118,186 (62.3%)

Diabetes (N = 200,758)

No

8,443 (77.4%)

180,475 (95.1%)

Yes

2,465 (22.6%)

9,375 (4.9%)

m-CCI score (N = 200,758)

Low

3,145 (28.8%)

133,599 (70.4%)

Moderate

4,232 (38.8%)

43,923 (23.14%)

High

3,531 (32.4%)

12,328 (6.5%)

SAB event (N = 200,758)

No

9,500 (87.1%)

189,117 (99.6%)

Yes

1,4081 (12.9%)

733 (0.4%)

  1. ESRD: end-stage renal disease; m-CCI: modified Charlson Comorbidity Index; SAB: Staphylococcal aureus bacteremia.
  2. NOTE. Baseline characteristics. Data are no. of individuals, unless otherwise indicated.
  3. 1Distribution of SAB events according to type of renal replacement therapy: renal transplantation = 23 events, hemodialysis = 1,069 events, and peritoneal dialysis = 316 events.